Bioventix Statistics

Total Valuation

Bioventix has a market cap or net worth of GBP 95.61 million. The enterprise value is 90.54 million.

Market Cap	95.61M
Enterprise Value	90.54M

Important Dates

The next estimated earnings date is Monday, December 29, 2025.

Earnings Date	Dec 29, 2025
Ex-Dividend Date	Nov 6, 2025

Share Statistics

Bioventix has 5.22 million shares outstanding. The number of shares has decreased by -0.08% in one year.

Current Share Class	5.22M
Shares Outstanding	5.22M
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	-0.15%
Owned by Insiders (%)	6.11%
Owned by Institutions (%)	71.08%
Float	4.15M

Valuation Ratios

The trailing PE ratio is 12.77 and the forward PE ratio is 13.45.

PE Ratio	12.77
Forward PE	13.45
PS Ratio	7.29
PB Ratio	8.28
P/TBV Ratio	8.28
P/FCF Ratio	13.63
P/OCF Ratio	13.60
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.91, with an EV/FCF ratio of 12.91.

EV / Earnings	11.94
EV / Sales	6.90
EV / EBITDA	8.91
EV / EBIT	8.99
EV / FCF	12.91

Financial Position

The company has a current ratio of 9.17

Current Ratio	9.17
Quick Ratio	4.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 64.40% and return on invested capital (ROIC) is 53.46%.

Return on Equity (ROE)	64.40%
Return on Assets (ROA)	47.35%
Return on Invested Capital (ROIC)	53.46%
Return on Capital Employed (ROCE)	87.20%
Revenue Per Employee	1.09M
Profits Per Employee	632,037
Employee Count	12
Asset Turnover	0.99
Inventory Turnover	1.84

Taxes

In the past 12 months, Bioventix has paid 2.51 million in taxes.

Income Tax	2.51M
Effective Tax Rate	24.88%

Stock Price Statistics

The stock price has decreased by -51.20% in the last 52 weeks. The beta is 0.63, so Bioventix's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-51.20%
50-Day Moving Average	2,179.30
200-Day Moving Average	2,531.70
Relative Strength Index (RSI)	31.57
Average Volume (20 Days)	22,737

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioventix had revenue of GBP 13.12 million and earned 7.58 million in profits. Earnings per share was 1.43.

Revenue	13.12M
Gross Profit	11.92M
Operating Income	10.07M
Pretax Income	10.10M
Net Income	7.58M
EBITDA	10.17M
EBIT	10.07M
Earnings Per Share (EPS)	1.43

Full Income Statement

Balance Sheet

The company has 5.08 million in cash and n/a in debt, giving a net cash position of 5.08 million or 0.97 per share.

Cash & Cash Equivalents	5.08M
Total Debt	n/a
Net Cash	5.08M
Net Cash Per Share	0.97
Equity (Book Value)	11.55M
Book Value Per Share	2.21
Working Capital	10.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.03 million and capital expenditures -19,189, giving a free cash flow of 7.01 million.

Operating Cash Flow	7.03M
Capital Expenditures	-19,189
Free Cash Flow	7.01M
FCF Per Share	1.34

Full Cash Flow Statement

Margins

Gross margin is 90.86%, with operating and profit margins of 76.80% and 57.83%.

Gross Margin	90.86%
Operating Margin	76.80%
Pretax Margin	76.97%
Profit Margin	57.83%
EBITDA Margin	77.51%
EBIT Margin	76.80%
FCF Margin	53.47%

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 8.20%.

Dividend Per Share	1.50
Dividend Yield	8.20%
Dividend Growth (YoY)	-3.23%
Years of Dividend Growth	1
Payout Ratio	108.05%
Buyback Yield	0.08%
Shareholder Yield	7.97%
Earnings Yield	7.93%
FCF Yield	7.33%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bioventix has an Altman Z-Score of 86.73 and a Piotroski F-Score of 4.

Altman Z-Score	86.73
Piotroski F-Score	4